WO2009081246A3 - Bicyclic diamines as nicotinic receptor agonists - Google Patents

Bicyclic diamines as nicotinic receptor agonists Download PDF

Info

Publication number
WO2009081246A3
WO2009081246A3 PCT/IB2008/003382 IB2008003382W WO2009081246A3 WO 2009081246 A3 WO2009081246 A3 WO 2009081246A3 IB 2008003382 W IB2008003382 W IB 2008003382W WO 2009081246 A3 WO2009081246 A3 WO 2009081246A3
Authority
WO
WIPO (PCT)
Prior art keywords
receptor agonists
nicotinic receptor
bicyclic diamines
diamines
bicyclic
Prior art date
Application number
PCT/IB2008/003382
Other languages
French (fr)
Other versions
WO2009081246A2 (en
Inventor
John Adams Lowe, Iii
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of WO2009081246A2 publication Critical patent/WO2009081246A2/en
Publication of WO2009081246A3 publication Critical patent/WO2009081246A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

Compounds; pharmaceutically acceptable salts thereof; and stereoisomers of the compound of Formula I and pharmaceutically acceptable salts thereof; are disclosed, wherein the compounds have the structure of Formula (I) as defined in the specification. Corresponding pharmaceutical compositions and methods of treatment are also disclosed.
PCT/IB2008/003382 2007-12-19 2008-12-04 Bicyclic diamines as nicotinic receptor agonists WO2009081246A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1496307P 2007-12-19 2007-12-19
US61/014,963 2007-12-19

Publications (2)

Publication Number Publication Date
WO2009081246A2 WO2009081246A2 (en) 2009-07-02
WO2009081246A3 true WO2009081246A3 (en) 2009-09-03

Family

ID=40350166

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/003382 WO2009081246A2 (en) 2007-12-19 2008-12-04 Bicyclic diamines as nicotinic receptor agonists

Country Status (1)

Country Link
WO (1) WO2009081246A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011291579B2 (en) * 2010-08-20 2016-11-10 Research Triangle Institute Nicotinic receptor compounds
JP6578349B2 (en) 2014-08-11 2019-09-18 アンジオン バイオメディカ コーポレーション Cytochrome P450 inhibitors and uses thereof
EP3240778A4 (en) 2014-12-31 2018-07-11 Angion Biomedica Corp. Methods and agents for treating disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044755A1 (en) * 1999-01-29 2000-08-03 Abbott Laboratories Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
US20020013309A1 (en) * 2000-05-25 2002-01-31 Miller Craig Harrison Pharmaceutical compositions and methods for use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000044755A1 (en) * 1999-01-29 2000-08-03 Abbott Laboratories Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
EP1359152A2 (en) * 1999-01-29 2003-11-05 Abbott Laboratories Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
US20020013309A1 (en) * 2000-05-25 2002-01-31 Miller Craig Harrison Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
WO2009081246A2 (en) 2009-07-02

Similar Documents

Publication Publication Date Title
WO2008012622A3 (en) Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor
MY148583A (en) Pyridine [3,4-b] pyrazinones
WO2007135527A3 (en) Benzimidazolyl compounds
WO2008077557A8 (en) 8-ethinylxanthine derivatives as selective a2a receptor antagonists
MX2010009163A (en) Heterocyclic urea derivatives and methods of use thereof-211.
WO2010038081A3 (en) 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
MX2010003155A (en) Cyclopropyl aryl amide derivatives and uses thereof.
WO2011114271A8 (en) 2,3 dihydro- 1h - inden- 1 - yl -2,7 -diazaspiro [ 3.5 ] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
WO2009010416A3 (en) Inhibitors of 11b-hydroxysteroid dehydrogenase
WO2008094992A3 (en) 2-aminopyridine derivatives useful as kinase inhibitors
MX2012000414A (en) Pyridin-4-yl derivatives.
WO2007150025A3 (en) Purinone derivatives as hm74a agonists
WO2007150026A3 (en) Purinone derivatives as hm74a agonists
UA92670C2 (en) Pyrazoline compounds as mineralocorticoid receptor antagonists , pharmaceutical use thereof, composition based thereon
WO2008121348A8 (en) Peripheral opioid receptor antagonists and uses thereof
WO2008001195A3 (en) Novel processes for the preparation of dpp iv inhibitors
IN2012DN03182A (en)
TW200633964A (en) Tetralin and indane derivatives and uses thereof
MX2009013501A (en) Piperidine compounds and uses thereof.
UA99787C2 (en) Lactams as beta secretase inhibitors
WO2008006795A3 (en) Indole compounds
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
WO2010049449A3 (en) Novel salts of sunitinib
WO2009156951A3 (en) 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine compounds
WO2011045232A3 (en) Neuropeptide-2 receptor (y-2r) agonists

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08865358

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08865358

Country of ref document: EP

Kind code of ref document: A2